Intravenous Iron May Reduce Platelet Counts in Patients with CKD

Among 203 patients with CKD who received low molecular-weight iron dextran over a median time of 2 hours and 40 minutes, average platelet counts were slightly reduced during consecutive 15-day intervals post-treatment. At the reference point of 90 days post-infusion, the drop in platelet count was statistically significant. The findings are published in the Journal of Clinical Pharmacy and Therapeutics. Additional studies are needed to examine whether the drop in platelet count translates to a reduction in thrombotic episodes.